Safety and tolerability of ibrutinib monotherapy in Japanese patients with relapsed/refractory B cell malignancies
Crossref DOI link: https://doi.org/10.1007/s12185-015-1900-3
Published Online: 2015-11-20
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tobinai, Kensei
Ogura, Michinori
Ishizawa, Kenichi
Suzuki, Tatsuya
Munakata, Wataru
Uchida, Toshiki
Aoki, Tomohiro
Morishita, Takanobu
Ushijima, Yoko
Takahara, Satoko
Text and Data Mining valid from 2015-11-20